Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Neuberg Centre For Genomic Medicine, |
RCV002510664 | SCV002820167 | uncertain significance | Epilepsy, familial focal, with variable foci 4 | criteria provided, single submitter | clinical testing | The stop gained p.E1683* in SCN3A (NM_006922.4) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.E1683* variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The nucleotide change in SCN3A is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. Since this variant is present in the last exon therefore it is classified as Variant of Uncertain Significance (VUS). Functional studies will be required to prove protein truncation and loss of function. For these reasons, this variant has been classified as Variant of Uncertain Significance (VUS). |